Glenmark Pharmaceuticals (India)

Recent papers from Glenmark Pharmaceuticals (India)

1. RELIEF-AD: Real-world effectiveness of mometasone furoate in itch reduction in pediatric atopic dermatitisIndian Journal of Skin Allergy · 2026
2. From stent to stability: Conservative management of post-stenting aortic dissection in coarctation of the aortaAnnals of Pediatric Cardiology · 2026
3. A retrospective study on the effectiveness and safety of the combination of intranasal corticosteroid and intranasal antihistamine in the management of patients with allergic rhinitisFrontiers in Allergy · 2026
4. Utilization Patterns of Nebulized Glycopyrronium in Patients Hospitalized for Acute Exacerbations of Obstructive Airway Disease (AEOAD)—Indian Expert PerspectivesAdvances in respiratory medicine · 2026
5. Clinical Validation of a QSP Model for ISB 2001, a Trispecific T Cell Engager to Support Optimal FIH Study Design in RRMM PatientsClinical Pharmacology & Therapeutics · 2026
6. Enhanced follicular delivery of minoxidil to human scalp skin using cetosomal formulation.2026
7. Effectiveness and Safety of Telmisartan Plus Amlodipine Compared to Telmisartan Plus Cilnidipine in Indian Patients with Hypertension and Renal Impairment: A Randomized, Open Label, Post Marketing Study (START Renal)International Journal of Nephrology and Renovascular Disease · 2026
8. Olopatadine plus mometasone for seasonal allergic rhinitis treatment: A pooled analysis of clinical trialsBrazilian Journal of Otorhinolaryngology · 2026
9. WCN26-8962 Effect on BP and Renal Outcomes with Cilnidipine-based therapy in Hypertensive CKD Patients with or without T2DM: A Two-Year Real-World AnalysisKidney International Reports · 2026
10. Applications of Artificial Intelligence in Intellectual Disability: Opportunities and Challenges in the Indian ContextJournal of Education Society and Behavioural Science · 2026
11. A Systematic Review and Meta-Analysis of Efficacy and Safety of Liraglutide in Patients with Type 2 Diabetes MellitusDiabetes Metabolic Syndrome and Obesity · 2026
12. The Atopic Dermatitis Patient Journey: From Awareness to Advanced CareCureus · 2026
13. An Open-Label, Single-Arm, Multicentric, Prospective, Phase IV Study to Evaluate the Safety and Effectiveness of Indacaterol/Mometasone/Glycopyrronium Dry Powder Inhaler (DPI) in the Management of Asthma Patients (OASIS Study)Cureus · 2025
14. Patterns of Bruton’s Tyrosine Kinase Inhibitor (BTKi) Usage in B-cell Lymphomas in India: A Questionnaire-Based StudyCureus · 2025
15. Effectiveness and Safety of Glycopyrronium–Formoterol–Budesonide Triple Therapy in Chronic Obstructive Pulmonary Disease (AIR-FORCE): An Open-Label Multi-Centric Phase 4 StudyAdvances in respiratory medicine · 2025
16. Triple arm, prospective, real-world study comparing the efficacy of FDC teneligliptin + dapagliflozin to FDC sitagliptin + dapagliflozin, and FDC linagliptin + empagliflozin in Indian type 2 diabetes mellitus patients using CGM device: the Amplify-TIR studyCardiovascular Diabetology – Endocrinology Reports · 2025
17. Practical Recommendations for Indians on Sunscreen Use—A Modified Delphi Consensus by Indian Sunscreen Forum (PRISM‐ISF)Journal of Cosmetic Dermatology · 2025
18. PRACT-India: Practical Recommendations on Acne Care and Medical Treatment in India—A Modified Delphi ConsensusAntibiotics · 2025
19. Sulfonated grapheneoxide as a sustainable metal free acid catalyst: a smart approach for synthesizing 1, 3, 4-oxadiazole derivatives from carboxylic acids: antimicrobial activitiesDiscover Catalysis. · 2025
20. Targeting the oral microbiome: Delivery of Lactobacillus paracasei through orodispersible tabletsAsian Journal of Oral Health and Allied Sciences · 2025